Dr. Jawad Haider Butt shared data demonstrating that a patient’s duration of living with type 2 diabetes does not impact treatment response to Forxiga. Credit:
Image credit: Shutterstock/ArDanMe On 30 August, at this year’s European Society of Cardiology (ESC) conference, during a late-breaking science session on the topic of “Pharmacotherapy,”
A study meant to serve as a tie-breaker between two major trials of a heart clip made by Abbott may end up stimulating more debate
Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before risk of contracting this potentially fatal infection dramatically
Researchers from the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital have found a new method to increase both speed and success rates
Patients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, an international study led by
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Novo Nordisk bolstered its heart disease data for semaglutide on Friday with additional analyses from a handful of trials. In a pooled analysis of certain
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Ipsen Pharmaceuticals sold its priority review voucher to an unidentified “large global pharmaceutical company” for $158 million, it said this week, the highest publicly announced